CIK 0001835597 · <br>Emerging growth company
PepGen Inc.
Sign in to watch- Ticker
- PEPG
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 703-456-8000
- Business address
- 1 MARINA PARK DRIVE, SUITE 900, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-19 | STRECK PAUL EVP, Head of R&D | Grant or award · Stock Option (Right to Buy) | +202,816 | 202,816 | ||
| 2024-08-19 | STRECK PAUL EVP, Head of R&D | Grant or award · Stock Option (Right to Buy) | +40,000 | 242,816 | ||
| 2024-07-25 | Mellion Michelle L Chief Medical Officer | Option exercise 10b5-1 | +7,571 | $10.21 | $77K | 7,571 |
| 2024-07-25 | Mellion Michelle L Chief Medical Officer | Sale 10b5-1 | −7,571 | $18.06 | $137K | 0 |
| 2024-07-25 | Mellion Michelle L Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,571 | 50,000 | ||
| 2024-07-24 | Mellion Michelle L Chief Medical Officer | Option exercise 10b5-1 | +201 | $10.21 | $2K | 201 |
| 2024-07-24 | Mellion Michelle L Chief Medical Officer | Sale 10b5-1 | −201 | $18.01 | $4K | 0 |
| 2024-07-24 | Mellion Michelle L Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −201 | 57,571 | ||
| 2024-07-18 | Mellion Michelle L Chief Medical Officer | Option exercise 10b5-1 | +12,625 | $10.21 | $129K | 12,625 |
| 2024-07-18 | Mellion Michelle L Chief Medical Officer | Sale 10b5-1 | −12,625 | $18.20 | $230K | 0 |
| 2024-07-18 | Mellion Michelle L Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,625 | 57,772 | ||
| 2024-07-16 | Mellion Michelle L Chief Medical Officer | Option exercise 10b5-1 | +5,901 | $10.21 | $60K | 5,901 |
| 2024-07-16 | Mellion Michelle L Chief Medical Officer | Sale 10b5-1 | −5,901 | $18.00 | $106K | 0 |
| 2024-07-16 | Mellion Michelle L Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,901 | 70,397 | ||
| 2024-07-12 | Mellion Michelle L Chief Medical Officer | Option exercise 10b5-1 | +3,288 | $10.21 | $34K | 3,288 |
| 2024-07-12 | Mellion Michelle L Chief Medical Officer | Sale 10b5-1 | −3,288 | $18.04 | $59K | 0 |
| 2024-07-12 | Mellion Michelle L Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,288 | 76,298 | ||
| 2024-07-02 | Mellion Michelle L Chief Medical Officer | Option exercise 10b5-1 | +37 | $10.21 | $378 | 37 |
| 2024-07-02 | Mellion Michelle L Chief Medical Officer | Sale 10b5-1 | −37 | $18.07 | $669 | 0 |
| 2024-07-02 | Mellion Michelle L Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −37 | 79,586 |
Page 5 of 11 · 211 trades